aceProspective multicentre expert evaluation of an artificial intelligence-based oncology clinical decision support system across major cancer types in India
Introduction: Cancer is a major public health challenge in India, with an estimated 1.4 million new cases each year. Despite this burden, the ratio of oncologists to new cancer patients is critically low, about one specialist per 1600 new diagnoses per year. The AI-driven CDSS could help offset the oncologist shortage in LMICs. OneRx.AI is an RAG platform grounded in international and national oncology guidelines. We evaluated its Expert-rated accuracy, clinical safety, Guideline concordance and decision impact,…
At three Indian tertiary cancer centres, oncologists using OneRx.AI reached clinical recommendations far faster, with high expert-rated accuracy, safety and guideline concordance.
The authors call the evaluation exploratory and ceiling-affected, and say it supports moving to a larger Stage II study rather than confirming performance.
Evidence
- Peer-reviewedInternational Journal of Medical Informatics2026-09-29
How should this claim be treated?
Truvace Impact Record TRV-2026-1504, v1: “Prospective multicentre expert evaluation of an artificial intelligence-based oncology clinical decision support system across major cancer types in India.” Truvace, 2026-10-15. /record/TRV-2026-1504 (accessed at citation time). sha256 5b2ec9f78088c24d…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-1504 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.